Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec 18;15(12):e50741.
doi: 10.7759/cureus.50741. eCollection 2023 Dec.

Rhabdomyolysis in the Context of Designer Benzodiazepine Misuse

Greg Noe  1 , Kaushal Shah  1 , Taylor Quattlebaum  1 , Sahil Munjal  1
Affiliations
Case Reports

Rhabdomyolysis in the Context of Designer Benzodiazepine Misuse

Greg Noe et al. Cureus. .

Abstract

Designer benzodiazepines belong to a class of lab-created psychoactive compounds, with limited federal regulation, no toxicity testing, and reported high potency, leading to substantial overdose risk and harmful clinical syndromes. Benzodiazepine misuse has been previously documented to be associated with rhabdomyolysis, with elevated creatine kinase (CK) during and after acute episodes of intoxication. Here, we present a case of profound rhabdomyolysis and associated acute kidney injury (AKI) after acute designer benzodiazepine intoxication. A 26-year-old male with a history of poly-substance misuse, including alcohol, psychedelics, opiates, kratom, and benzodiazepines, presented to the emergency department with altered mental status and agitation after an accidental overdose on liquid flubromazolam and clonazolam, designer benzodiazepines purchased online. He went on to develop seizure-like activity. Additional labs revealed AKI with creatinine 2.22 mg/dL (reference 0.74-1.35 mg/dL, baseline 0.88 mg/dL). He was discovered to have severe rhabdomyolysis that peaked at 131,920 U/L (reference 55-170 U/L) on the fourth day of admission. This case demonstrates the potential deleterious effects of the designer benzodiazepine class, including prolonged sedation, AKI, and severe rhabdomyolysis. In addition, seizure-like manifestations may occur during the intoxication or withdrawal phase. Designer benzodiazepines may produce rhabdomyolysis; however, the mechanism is unknown. Direct myotoxicity or prolonged immobilization may be contributors to rhabdomyolysis. More research is needed to elucidate the consequences of designer benzodiazepine misuse. Clinicians should be aware of their use given the ease of availability online and rising popularity.

Keywords: acute kidney injury; designer benzodiazepines; designer drugs; drug overdose; elevated creatine kinase; rhabdomyolysis; substance misuse.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

See all similar articles

References

    1. Flubromazolam overdose: a review of a new designer benzodiazepine and the role of flumazenil. Bohnenberger K, Liu MT. Ment Health Clin. 2019;9:133–137. - PMC - PubMed
    1. Flubromazolam--a new life-threatening designer benzodiazepine. Łukasik-Głębocka M, Sommerfeld K, Teżyk A, Zielińska-Psuja B, Panieński P, Żaba C. Clin Toxicol (Phila) 2016;54:66–68. - PubMed
    1. Clinical toxicology of newer recreational drugs. Hill SL, Thomas SH. Clin Toxicol (Phila) 2011;49:705–719. - PubMed
    1. Overdose from designer benzodiazepine diclazepam. Runnstrom M, Kalra SS, Lascano J, Patel DC. QJM. 2020;113:122–124. - PubMed
    1. Rhabdomyolysis and acute renal failure following an overdose of doxepine and nitrazepam. Højgaard AD, Andersen PT, Møller-Petersen J. Acta Med Scand. 1988;223:79–82. - PubMed

Publication types

LinkOut - more resources